fenofibrate has been researched along with nephrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Ding, J; Guan, Y; Kong, X; Miao, J; Yang, H; Yang, J; Zhang, X; Zhao, P; Zhou, Y | 1 |
| Mori, K; Mukoyama, M; Nakao, K | 1 |
2 other study(ies) available for fenofibrate and nephrin
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury.
Topics: Animals; Apoptosis; Caspase 3; Cell Line; Cytoprotection; Disease Models, Animal; Doxorubicin; Fenofibrate; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Knockout; Podocytes; PPAR alpha; Proteinuria; Proto-Oncogene Proteins c-bcl-2; Species Specificity; Time Factors; Transcription, Genetic | 2011 |
PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice.
Topics: Animals; Apoptosis; Caspase 3; Cytoprotection; Disease Models, Animal; Doxorubicin; Fenofibrate; Kidney Diseases; Kidney Glomerulus; Membrane Proteins; Mice; Mice, Knockout; Podocytes; PPAR alpha; Proteinuria; Proto-Oncogene Proteins c-bcl-2; Time Factors; Transcription, Genetic | 2011 |